An estimated 5 million patients worldwide suffer from the autoimmune disease and in Australia and New zealand, autoimmune diseases affect around 1 in 20 people.Our research will investigate patients samples and animal models to identify the pathogenesis of autoimmune disease and establish new monitor systems and better therapeutic treatments of autoimmune diseases.
Visceral Sensation In Complicated And Uncomplicated Upper Gastrointestinal Disease
Funder
National Health and Medical Research Council
Funding Amount
$66,929.00
Summary
50% of patients with complications of peptic ulcer (bleeding) and gastroesophageal reflux disease (Barrett's Oesophagus) have no symptoms of their diseases. In contrast, 50% of patients who seek treatment for gastrointestinal symptoms are found to have no cause after investigations. The aims of this study are to explore differences in sensation, muscular function and genetic factors between patients with functional gastrointestinal disorders and patients with complicated organic disorders.
Characterisation Of The Molecular Pathogenesis Of Cancer Cachexia Syndrome In Colorectal Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$100,381.00
Summary
Cachexia is a hypermetabolic wasting syndrome involving depletion of both fat and muscle which affects 80% of cancer patients. The exact mechanisms of this syndrome are unknown at the molecular level and this affects our ability to predict, prevent or treat this problem. This study aims to elucidate the molecular mechanisms of cancer cachexia syndrome with a view to implementing nutritional, exercise and pharmacological interventions to prevent its onset.